Carl Zeiss Meditec AG

AFX

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,784

Stocks News & Analysis

stocks

Shares leap for ASX rare earths provider

We increased our fair value based on higher expected rare earths pricing.
stocks

Strong growth from ASX listed data centre provider

A wall of demand is driving revenue growth.
stocks

Does SpaceX’s sky-high valuation make sense?

SpaceX’s $1.5 trillion valuation looks expensive and risky, but not irrational.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,851.4029.00-0.33%
CAC 407,984.4457.37-0.71%
DAX 4023,589.6550.38-0.21%
Dow JONES (US)46,677.85739.42-1.56%
FTSE 10010,264.7189.06-0.86%
HKSE25,716.76182.00-0.70%
NASDAQ22,311.98404.16-1.78%
Nikkei 22554,452.96572.41-1.04%
NZX 50 Index13,141.0158.28-0.44%
S&P 5006,672.62103.18-1.52%
S&P/ASX 2008,629.0014.20-0.16%
SSE Composite Index4,129.104.33-0.10%

Market Movers